好处
消化健康:益生菌有助于维持肠道细菌的健康平衡,这对于正常消化和营养吸收至关重要。它们支持食物的分解、消化酶的产生以及预防胃肠道问题,例如腹胀、胀气和便秘。400 亿多种益生菌补充剂可能有助于促进规律性、缓解消化不适并支持整体消化健康。
免疫功能:肠道微生物群在免疫功能中起着关键作用,因为它与免疫细胞相互作用并有助于调节免疫反应。益生菌刺激抗体的产生,增强免疫细胞的活性,并调节肠道和全身的炎症。400 亿多种益生菌补充剂可能有助于增强免疫系统,降低感染风险,并支持整体免疫功能和恢复力。
肠道屏障功能:益生菌有助于维持肠道屏障的完整性,从而防止有害病原体和毒素进入血液。它们增强粘蛋白(覆盖肠壁的保护层)的产生,并促进紧密连接蛋白的表达,从而密封肠道细胞之间的间隙。400 亿多种益生菌补充剂可能有助于增强肠道屏障,降低肠道通透性(“肠漏”),并预防胃肠道感染和炎症。
抗炎作用:益生菌具有抗炎特性,有助于减少肠道和全身的炎症。它们会产生短链脂肪酸 (SCFA),例如丁酸,具有抗炎作用并有助于维持肠道屏障功能。益生菌还调节参与免疫反应的细胞因子和其他炎症分子的产生。40 Billion Multi Probiotics 补充剂可能有助于缓解炎症性肠病 (IBD) 的症状,例如克罗恩病和溃疡性结肠炎,并降低患慢性炎症相关疾病的风险。
情绪和心理健康:肠脑轴是肠道和大脑之间的双向通讯系统,由微生物群、神经系统和免疫系统介导。益生菌会影响神经递质的产生、应激激素的调节和情绪相关途径,从而影响情绪和心理健康。40 Billion Multi Probiotics 补充剂可能有助于改善情绪、减轻焦虑和抑郁的症状并支持整体心理健康。
抗生素相关副作用:抗生素会破坏肠道细菌平衡,导致腹泻、腹胀和酵母菌过度生长等胃肠道副作用。益生菌有助于恢复肠道微生物平衡,缓解抗生素相关副作用。在抗生素治疗期间和之后服用 40 Billion Multi Probiotics 补充剂可能有助于预防或减轻这些副作用的严重程度,并促进肠道健康更快恢复。
阴道和泌尿道健康:益生菌在维持阴道和泌尿道有益细菌平衡方面发挥着作用,有助于预防细菌性阴道病和泌尿道感染 (UTI) 等感染。益生菌会产生抗菌物质,与病原体竞争营养和粘附部位,并调节局部免疫反应。含有专门针对阴道和泌尿健康的菌株的 40 Billion Multi Probiotics 补充剂可能有助于预防复发性感染并促进整体泌尿生殖系统健康。
Medicinal Ingredients (per 2 capsules):
Lactobacillus casei (HA-108)……………………..7.0
Lactobacillus rhamnosus (HA-111)…………..7.0
Bifidobacterium breve (HA-129)……………….5.0
Bifidobacterium longum (HA-135)……………5.0
Lactobacillus paracasei (HA-108)……………….4.0
Bifidobacterium bifidum (HA-132)……………3.0
Lactobacillus acidophilus (HA-122)…………..2.0
Bifidobacterium animalis (HA-194)………….2.0
Lactobacillus plantarum (HA-119)……………..2.0
Lactobacillus fermentum (HA-179)……………2.0
Lactobacillus salivarius (HA-118)……………….2.0 (A minimum of 40 Billion CFU guaranteed at expiry date. A minimum of 66 Billion at time of manufacture).
Non-Medicinal Ingredients:
Fructooligosaccharide, Silica/e, Hypromellose
Recommended Dose:
Adults: 1 Capsule 2 times per day.
Cautions and Warnings:
If you have fever, vomiting, bloody diarrhoea or severe abdominal pain, consult a health care practitioner prior to use. If symptoms of digestive upset (e.g. diarrhea) occur, worsen, or persist beyond 3 days, discontinue use and consult a health care practitioner.
Do not use if you have an allergy to dairy or soy product.
Q: What are the Health Canada approved uses for this product?
A: This product is approved by Health Canada (NPN 80071438) for the following uses: helps support a healthy gut flora; helps reduce the frequency of colds; helps relieve gastrointestinal symptoms associated with antibiotic use; and promotes a favourable gut flora. This product is not intended to diagnose, treat, cure, or prevent any disease.
Q: What does "40 Billion CFU guaranteed at expiry" mean?
A: CFU stands for Colony Forming Unit the standard measure of viable, living probiotic bacteria. Many probiotic supplements state their CFU count at the time of manufacture, but probiotic bacteria die over time even in encapsulated form. This formula guarantees a minimum of 40 Billion CFU per serving at the expiry date. To achieve this, it is manufactured with a minimum of 66 Billion CFU per serving a 65% overage to account for natural bacterial die-off during storage. The guarantee applies from the first capsule to the last, regardless of where the product is in its shelf life.
Q: What strains are in this formula and how are they distributed?
A: The formula contains 11 strains across two genera. The Lactobacillus strains are: Lactobacillus casei (HA-108) at 7.0 Billion CFU, Lactobacillus rhamnosus (HA-111) at 7.0 Billion CFU, Lactobacillus paracasei (HA-196) at 4.0 Billion CFU, Lactobacillus acidophilus (HA-122) at 2.0 Billion CFU, Lactobacillus plantarum (HA-119) at 2.0 Billion CFU, Lactobacillus fermentum (HA-179) at 2.0 Billion CFU, and Lactobacillus salivarius (HA-118) at 2.0 Billion CFU. The Bifidobacterium strains are: Bifidobacterium breve (HA-129) at 5.0 Billion CFU, Bifidobacterium longum (HA-135) at 5.0 Billion CFU, Bifidobacterium bifidum (HA-132) at 3.0 Billion CFU, and Bifidobacterium animalis (HA-194) at 2.0 Billion CFU. The Bifidobacterium strains together contribute approximately 15 Billion CFU, representing approximately 37% of the total guaranteed CFU count.
Q: What makes Bifidobacterium animalis significant in this formula?
A: Bifidobacterium animalis (HA-194) is notable among Bifidobacterium species for its resilience and ability to survive transit through the gastrointestinal tract. Probiotic bacteria must survive the acidic environment of the stomach and the bile salts of the small intestine before reaching the large intestine, where Bifidobacterium species exert their primary effects. B. animalis is among the most studied Bifidobacterium species for gastrointestinal transit survival and is one of the most commonly used Bifidobacterium strains in clinical probiotic research. Its inclusion alongside B. breve, B. longum, and B. bifidum gives this formula a comprehensive Bifidobacterium profile covering multiple species found in the healthy adult gut microbiome.
Q: Why does this formula emphasize Bifidobacterium strains?
A: Bifidobacterium species are among the most important beneficial bacteria in the human large intestine (colon), where they are among the most abundant bacterial genera in healthy adults. They ferment dietary fibers and prebiotics such as FOS in the large intestine, producing short-chain fatty acids (SCFAs) including acetate and lactate, which are the primary energy source for colonocytes — the cells lining the colon. Bifidobacterium species also interact with immune cells in the gut-associated lymphoid tissue (GALT) and play important roles in maintaining the intestinal environment. Critically, Bifidobacterium species decline in relative abundance with age in adults, making their supplementation increasingly relevant as part of a gut flora support strategy. A formula with strong Bifidobacterium representation addresses the large intestine microbiome specifically, complementing the small intestine focus of Lactobacillus species.
Q: What is FOS and why is it included?
A: FOS (fructooligosaccharide) is a prebiotic a non-digestible carbohydrate that selectively feeds beneficial bacteria in the gut. It is found naturally in chicory root, Jerusalem artichoke, garlic, onion, leek, asparagus, and banana. FOS passes intact through the stomach and small intestine to the large intestine, where it is selectively fermented by Lactobacillus and Bifidobacterium species the same genera present in this formula. By including FOS alongside the probiotic strains, this formula provides the bacteria with a preferred substrate to support their survival and activity in the gut. A product that combines both probiotics and a prebiotic is called a synbiotic, making this a synbiotic formula.
Q: Why is Lactobacillus rhamnosus particularly relevant for antibiotic use?
A: Lactobacillus rhamnosus (HA-111) is one of the most extensively researched probiotic species globally and is among the most studied strains specifically for use during and after antibiotic therapy. Antibiotics disrupt the gut microbiome by reducing populations of beneficial bacteria alongside the targeted pathogens, which is the primary cause of antibiotic-associated gastrointestinal symptoms including diarrhea, bloating, and abdominal discomfort. L. rhamnosus is among the most documented probiotic species for supporting gut flora restoration during and after antibiotic use. At 7.0 Billion CFU, it is one of the two highest-CFU strains in this formula. Health Canada has approved this product (NPN 80071438) for helping relieve gastrointestinal symptoms associated with antibiotic use.
Q: What is the daily dose and how long does one bottle last?
A: The suggested use is 2 capsules per day, providing a minimum of 40 Billion CFU. The 60-capsule bottle provides a 30-day supply at this dose. Consult your healthcare provider to determine the appropriate dosage and timing for your individual needs.
Q: Is this product suitable for vegans and vegetarians?
A: Yes, this probiotic supplement is 100% vegan and suitable for both vegans and vegetarians. The probiotic strains are bacteria, not animal-derived. The capsule shell is made from hypromellose (vegetable cellulose), not gelatin. The FOS prebiotic is derived from plant sources. All non-medicinal ingredients (fructooligosaccharide, silica, hypromellose) are plant-derived or mineral-based. The product is also non-GMO and free from gluten, dairy, and soy.
Q: Are there any safety considerations I should know about?
A: Consult a healthcare professional before use if you are pregnant or breastfeeding, have a compromised immune system, or have a central venous catheter. Individuals with severely compromised immune systems should consult a healthcare provider before using probiotic supplements. May cause mild gastrointestinal discomfort including bloating and gas during the first few days of use as the gut flora adjusts; this typically resolves with continued use. This product is not intended to diagnose, treat, cure, or prevent any disease.
Nutridom 多种益生菌,400 亿菌落形成单位(60 粒胶囊)加拿大制造,高品质,支持消化健康,增强免疫功能,促进肠道菌群平衡,减少腹胀和胀气,支持营养吸收
- Unit price
- / per
Health Canada Licensed Natural Health Product (NPN 80071438)
Adding product to your cart
好处
消化健康:益生菌有助于维持肠道细菌的健康平衡,这对于正常消化和营养吸收至关重要。它们支持食物的分解、消化酶的产生以及预防胃肠道问题,例如腹胀、胀气和便秘。400 亿多种益生菌补充剂可能有助于促进规律性、缓解消化不适并支持整体消化健康。
免疫功能:肠道微生物群在免疫功能中起着关键作用,因为它与免疫细胞相互作用并有助于调节免疫反应。益生菌刺激抗体的产生,增强免疫细胞的活性,并调节肠道和全身的炎症。400 亿多种益生菌补充剂可能有助于增强免疫系统,降低感染风险,并支持整体免疫功能和恢复力。
肠道屏障功能:益生菌有助于维持肠道屏障的完整性,从而防止有害病原体和毒素进入血液。它们增强粘蛋白(覆盖肠壁的保护层)的产生,并促进紧密连接蛋白的表达,从而密封肠道细胞之间的间隙。400 亿多种益生菌补充剂可能有助于增强肠道屏障,降低肠道通透性(“肠漏”),并预防胃肠道感染和炎症。
抗炎作用:益生菌具有抗炎特性,有助于减少肠道和全身的炎症。它们会产生短链脂肪酸 (SCFA),例如丁酸,具有抗炎作用并有助于维持肠道屏障功能。益生菌还调节参与免疫反应的细胞因子和其他炎症分子的产生。40 Billion Multi Probiotics 补充剂可能有助于缓解炎症性肠病 (IBD) 的症状,例如克罗恩病和溃疡性结肠炎,并降低患慢性炎症相关疾病的风险。
情绪和心理健康:肠脑轴是肠道和大脑之间的双向通讯系统,由微生物群、神经系统和免疫系统介导。益生菌会影响神经递质的产生、应激激素的调节和情绪相关途径,从而影响情绪和心理健康。40 Billion Multi Probiotics 补充剂可能有助于改善情绪、减轻焦虑和抑郁的症状并支持整体心理健康。
抗生素相关副作用:抗生素会破坏肠道细菌平衡,导致腹泻、腹胀和酵母菌过度生长等胃肠道副作用。益生菌有助于恢复肠道微生物平衡,缓解抗生素相关副作用。在抗生素治疗期间和之后服用 40 Billion Multi Probiotics 补充剂可能有助于预防或减轻这些副作用的严重程度,并促进肠道健康更快恢复。
阴道和泌尿道健康:益生菌在维持阴道和泌尿道有益细菌平衡方面发挥着作用,有助于预防细菌性阴道病和泌尿道感染 (UTI) 等感染。益生菌会产生抗菌物质,与病原体竞争营养和粘附部位,并调节局部免疫反应。含有专门针对阴道和泌尿健康的菌株的 40 Billion Multi Probiotics 补充剂可能有助于预防复发性感染并促进整体泌尿生殖系统健康。
Medicinal Ingredients (per 2 capsules):
Lactobacillus casei (HA-108)……………………..7.0
Lactobacillus rhamnosus (HA-111)…………..7.0
Bifidobacterium breve (HA-129)……………….5.0
Bifidobacterium longum (HA-135)……………5.0
Lactobacillus paracasei (HA-108)……………….4.0
Bifidobacterium bifidum (HA-132)……………3.0
Lactobacillus acidophilus (HA-122)…………..2.0
Bifidobacterium animalis (HA-194)………….2.0
Lactobacillus plantarum (HA-119)……………..2.0
Lactobacillus fermentum (HA-179)……………2.0
Lactobacillus salivarius (HA-118)……………….2.0 (A minimum of 40 Billion CFU guaranteed at expiry date. A minimum of 66 Billion at time of manufacture).
Non-Medicinal Ingredients:
Fructooligosaccharide, Silica/e, Hypromellose
Recommended Dose:
Adults: 1 Capsule 2 times per day.
Cautions and Warnings:
If you have fever, vomiting, bloody diarrhoea or severe abdominal pain, consult a health care practitioner prior to use. If symptoms of digestive upset (e.g. diarrhea) occur, worsen, or persist beyond 3 days, discontinue use and consult a health care practitioner.
Do not use if you have an allergy to dairy or soy product.
Q: What are the Health Canada approved uses for this product?
A: This product is approved by Health Canada (NPN 80071438) for the following uses: helps support a healthy gut flora; helps reduce the frequency of colds; helps relieve gastrointestinal symptoms associated with antibiotic use; and promotes a favourable gut flora. This product is not intended to diagnose, treat, cure, or prevent any disease.
Q: What does "40 Billion CFU guaranteed at expiry" mean?
A: CFU stands for Colony Forming Unit the standard measure of viable, living probiotic bacteria. Many probiotic supplements state their CFU count at the time of manufacture, but probiotic bacteria die over time even in encapsulated form. This formula guarantees a minimum of 40 Billion CFU per serving at the expiry date. To achieve this, it is manufactured with a minimum of 66 Billion CFU per serving a 65% overage to account for natural bacterial die-off during storage. The guarantee applies from the first capsule to the last, regardless of where the product is in its shelf life.
Q: What strains are in this formula and how are they distributed?
A: The formula contains 11 strains across two genera. The Lactobacillus strains are: Lactobacillus casei (HA-108) at 7.0 Billion CFU, Lactobacillus rhamnosus (HA-111) at 7.0 Billion CFU, Lactobacillus paracasei (HA-196) at 4.0 Billion CFU, Lactobacillus acidophilus (HA-122) at 2.0 Billion CFU, Lactobacillus plantarum (HA-119) at 2.0 Billion CFU, Lactobacillus fermentum (HA-179) at 2.0 Billion CFU, and Lactobacillus salivarius (HA-118) at 2.0 Billion CFU. The Bifidobacterium strains are: Bifidobacterium breve (HA-129) at 5.0 Billion CFU, Bifidobacterium longum (HA-135) at 5.0 Billion CFU, Bifidobacterium bifidum (HA-132) at 3.0 Billion CFU, and Bifidobacterium animalis (HA-194) at 2.0 Billion CFU. The Bifidobacterium strains together contribute approximately 15 Billion CFU, representing approximately 37% of the total guaranteed CFU count.
Q: What makes Bifidobacterium animalis significant in this formula?
A: Bifidobacterium animalis (HA-194) is notable among Bifidobacterium species for its resilience and ability to survive transit through the gastrointestinal tract. Probiotic bacteria must survive the acidic environment of the stomach and the bile salts of the small intestine before reaching the large intestine, where Bifidobacterium species exert their primary effects. B. animalis is among the most studied Bifidobacterium species for gastrointestinal transit survival and is one of the most commonly used Bifidobacterium strains in clinical probiotic research. Its inclusion alongside B. breve, B. longum, and B. bifidum gives this formula a comprehensive Bifidobacterium profile covering multiple species found in the healthy adult gut microbiome.
Q: Why does this formula emphasize Bifidobacterium strains?
A: Bifidobacterium species are among the most important beneficial bacteria in the human large intestine (colon), where they are among the most abundant bacterial genera in healthy adults. They ferment dietary fibers and prebiotics such as FOS in the large intestine, producing short-chain fatty acids (SCFAs) including acetate and lactate, which are the primary energy source for colonocytes — the cells lining the colon. Bifidobacterium species also interact with immune cells in the gut-associated lymphoid tissue (GALT) and play important roles in maintaining the intestinal environment. Critically, Bifidobacterium species decline in relative abundance with age in adults, making their supplementation increasingly relevant as part of a gut flora support strategy. A formula with strong Bifidobacterium representation addresses the large intestine microbiome specifically, complementing the small intestine focus of Lactobacillus species.
Q: What is FOS and why is it included?
A: FOS (fructooligosaccharide) is a prebiotic a non-digestible carbohydrate that selectively feeds beneficial bacteria in the gut. It is found naturally in chicory root, Jerusalem artichoke, garlic, onion, leek, asparagus, and banana. FOS passes intact through the stomach and small intestine to the large intestine, where it is selectively fermented by Lactobacillus and Bifidobacterium species the same genera present in this formula. By including FOS alongside the probiotic strains, this formula provides the bacteria with a preferred substrate to support their survival and activity in the gut. A product that combines both probiotics and a prebiotic is called a synbiotic, making this a synbiotic formula.
Q: Why is Lactobacillus rhamnosus particularly relevant for antibiotic use?
A: Lactobacillus rhamnosus (HA-111) is one of the most extensively researched probiotic species globally and is among the most studied strains specifically for use during and after antibiotic therapy. Antibiotics disrupt the gut microbiome by reducing populations of beneficial bacteria alongside the targeted pathogens, which is the primary cause of antibiotic-associated gastrointestinal symptoms including diarrhea, bloating, and abdominal discomfort. L. rhamnosus is among the most documented probiotic species for supporting gut flora restoration during and after antibiotic use. At 7.0 Billion CFU, it is one of the two highest-CFU strains in this formula. Health Canada has approved this product (NPN 80071438) for helping relieve gastrointestinal symptoms associated with antibiotic use.
Q: What is the daily dose and how long does one bottle last?
A: The suggested use is 2 capsules per day, providing a minimum of 40 Billion CFU. The 60-capsule bottle provides a 30-day supply at this dose. Consult your healthcare provider to determine the appropriate dosage and timing for your individual needs.
Q: Is this product suitable for vegans and vegetarians?
A: Yes, this probiotic supplement is 100% vegan and suitable for both vegans and vegetarians. The probiotic strains are bacteria, not animal-derived. The capsule shell is made from hypromellose (vegetable cellulose), not gelatin. The FOS prebiotic is derived from plant sources. All non-medicinal ingredients (fructooligosaccharide, silica, hypromellose) are plant-derived or mineral-based. The product is also non-GMO and free from gluten, dairy, and soy.
Q: Are there any safety considerations I should know about?
A: Consult a healthcare professional before use if you are pregnant or breastfeeding, have a compromised immune system, or have a central venous catheter. Individuals with severely compromised immune systems should consult a healthcare provider before using probiotic supplements. May cause mild gastrointestinal discomfort including bloating and gas during the first few days of use as the gut flora adjusts; this typically resolves with continued use. This product is not intended to diagnose, treat, cure, or prevent any disease.
Canadian-Made
Lab-Tested
Health Canada Approved